Analysts Issue Forecasts for BIOX FY2026 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Research analysts at Brookline Capital Management reduced their FY2026 EPS estimates for shares of Bioceres Crop Solutions in a research note issued to investors on Thursday, February 13th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings per share of $0.46 for the year, down from their prior estimate of $0.61. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is $0.12 per share.

A number of other analysts also recently issued reports on BIOX. Oppenheimer dropped their price target on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating on the stock in a report on Tuesday, January 28th. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a report on Thursday, February 13th. Finally, Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a report on Friday, February 7th. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $9.88.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX traded down $0.13 during trading on Friday, reaching $4.83. 529,796 shares of the company traded hands, compared to its average volume of 308,270. The firm has a 50 day simple moving average of $6.39 and a 200-day simple moving average of $7.49. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $302.89 million, a PE ratio of 241.62 and a beta of 0.57. Bioceres Crop Solutions has a 52-week low of $4.42 and a 52-week high of $13.60.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently made changes to their positions in BIOX. Fourth Sail Capital LP boosted its holdings in shares of Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock worth $24,957,000 after buying an additional 1,209,277 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Bioceres Crop Solutions by 135.0% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company's stock worth $4,574,000 after purchasing an additional 432,206 shares in the last quarter. Long Focus Capital Management LLC increased its stake in Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after buying an additional 421,931 shares in the last quarter. Ballast Asset Management LP lifted its position in shares of Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after acquiring an additional 82,187 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Bioceres Crop Solutions by 49.3% in the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock valued at $708,000 after acquiring an additional 29,693 shares in the last quarter. Hedge funds and other institutional investors own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.